Bliss GVS Pharma506197Pharmaceuticals
Anupam Rasayan, promoter entity of Bliss GVS, acquired an additional 2.12% stake to cross the 50% threshold after its earlier open offer failed
- Additional stake acquired
- 2.12 percent
- Deal value
- 162.74 crore rupees
- Purchase price
- 723 rupees per share
- Stock move
- 4.64 percent
- Earlier open offer price
- 299 rupees per share
Heard on Live TV News Channel between 08:20:03 - 08:21:18 IST.
- Anupam Rasayan acquired a further 2.12% stake for ₹162.74 crores at about ₹723 per share.
- Stock was up 4.64% on the news.
- Anupam had earlier done an open offer at ₹299 per share which fell short of the 50% threshold needed for consolidation.
- Analyst said this buy at a much higher price was necessary to cross 50% and consolidate Bliss GVS into Anupam Rasayan's books, not a conviction buy on valuation.
- Analyst termed it not negative but also not a strong positive signal since it was a forced move.
Also from Bliss GVS Pharma
Bliss GVS Pharma Ltd shareholder buys 47.95% stake
6 Oct 2026
Board approves Senior Executive ESOP 2026 and Employee ESOP 2026; options up to 26,50,000 and 47,00,000 shares
1 Oct 2026
Bliss GVS Pharma Ltd promoter buys 47.95% stake, holding rises to 50.07%^#%
1 Oct 2026
Source: Live TV News Channel · 29 Sep 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.